A new study published in The Lancet Regional Health found that use of GLP-1 receptor agonists in the context of weight-loss treatment is associated with declines in lean (muscle) mass unless accompanied by targeted strength training interventions
Peckham, D., Holland, E., Range, S
D.AizensteinH
(It should be noted that children tend to have lower levels than adults, but the laboratory did not have a pediatric reference range.) After administration of DMSA, there was little change in the average level (a small decrease, not statistically significant), but the standard deviation became dramatically smaller
Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including the GHRP-2 and CJC-1295 No DAC research vials, are designated strictly for laboratory research purposes only